 |
5-(4-carboxymethyl-phenylazo)-2-hydroxybenzoic acid disodium salt |
|---|---|
| Trade Name | |
| Orphan Indication | Ulcerative colitis |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-31 00:00:00 |
| Sponsor | Innovate Biopharmaceuticals, Inc.;8480 Honeycutt Road, Suite 200;Raleigh, North Carolina, 27615 |
Related Access Program